Cooper Companies | COO - Selling And Administration Expenses


Cooper Companies reported $401.3M in Selling and Administration Expenses for its fiscal quarter ending in June of 2026.





Selling And Administration Expenses Change Date
Abbott USD 4.27B 669M Sep/2026
Align Technology USD 462.67M 2.67M Jun/2026
AtriCure USD 82.56M 1.99M Jun/2026
Bausch Health Companies USD 901M 88M Jun/2026
Baxter International USD 735M 7M Jun/2026
Bayer EUR 3.96B 267M Jun/2026
Becton, Dickinson and Co. USD 1.26B 48M Jun/2026
Boston Scientific USD 1.8B 22M Jun/2026
Cooper Companies USD 401.3M 274.9M Jun/2026
Dentsply International USD 364M 13M Jun/2026
Dexcom USD 358.7M 9M Jun/2026
Edwards Lifesciences USD 561.2M 39M Jun/2026
Globus Medical USD 286.82M 10.95M Jun/2026
Haemonetics USD 118.94M 1.99M Jun/2026
Inogen USD 43.77M 510K Jun/2024
Insulet USD 344.8M 27.6M Jun/2026
Integra LifeSciences USD 161.02M 5.2M Sep/2026
Intuitive Surgical USD 1.08B 465.5M Sep/2026
J&J USD 6.25B 168M Sep/2026
Medtronic 3.2B 141M Jun/2026
Merit Medical Systems USD 129.23M 18.76M Jun/2026
Novartis USD 3.14B 296M Mar/2026
ResMed USD 290.65M 10.86M Jun/2026
STAAR Surgical USD 45.14M 6.5M Jun/2026
Steris USD 369.7M 17.9M Jun/2026
Stryker USD 2.12B 32M Jun/2026
Tandem Diabetes Care USD 111.64M 3.45M Jun/2026
Teleflex USD 213.52M 12.5M Jun/2026
Utah Medical Products USD 2.56M 48K Mar/2026
Zimmer Biomet Holdings USD 911.6M 61.7M Jun/2026